GoodRx Holdings (GDRX) Total Debt (2019 - 2026)

GoodRx Holdings' Total Debt history runs 8 years deep, the most recent figure standing at $487.4 million for Q1 2026.

• In Q1 2026, Total Debt fell 0.7% year-over-year to $487.4 million; the TTM figure through Mar 2026 stood at $487.4 million (down 0.7% YoY), while the FY2025 annual figure was $488.3 million, down 0.7% from the prior year.
• Total Debt came in at $487.4 million for Q1 2026 at GoodRx Holdings, roughly flat from $488.3 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $661.9 million in Q1 2022 to a low of $487.4 million in Q1 2026.
• A 5-year average of $588.4 million and a median of $653.7 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt retreated 0.35% in 2023 and declined 25.1% in 2024, its largest moves.
• GoodRx Holdings' Total Debt stood at $658.8 million in 2022, then retreated by 0.35% to $656.5 million in 2023, then slipped by 25.1% to $491.7 million in 2024, then decreased by 0.7% to $488.3 million in 2025, then retreated by 0.17% to $487.4 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $487.4 million, $488.3 million, and $489.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison